itraconazole has been researched along with Hepatic Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igawa, Y; Ishizuka, H; Ishizuka, T; Shimizu, T; Watanabe, A; Yamada, M | 1 |
| Ben-Ami, R; Brenner, S; Levtov, S; Srebrnik, A | 1 |
1 trial(s) available for itraconazole and Hepatic Failure
| Article | Year |
|---|---|
Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.
Topics: Antihypertensive Agents; Area Under Curve; Computer Simulation; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Healthy Volunteers; Humans; Itraconazole; Japan; Liver Failure; Metabolic Clearance Rate; Models, Biological; Pyrroles; Rifampin; Sulfones | 2022 |
1 other study(ies) available for itraconazole and Hepatic Failure
| Article | Year |
|---|---|
Liver failure and transplantation after itraconazole treatment for toenail onychomycosis.
Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Liver Failure; Liver Function Tests; Liver Transplantation; Onychomycosis | 2005 |